Sleep duration
Sleep duration has been studied in 672 papers since 2015: 2 trials and 629 observational studies in people, 1 in animals, 38 reviews; 255 in the past year. The newest paper, Nov 20, 2026: “Sleep characteristics, glymphatic proxies, and ATN biomarkers in Alzheimer’s disease”.
Research on it is growing 25% faster than aging research as a whole: 56 papers in the latest year counted
57 new papers in 30 daysSee all 671 papers on sleep duration
At a glance
Sleep duration is linked with mortality, cognitive function and frailty in human observational studies, with independent labs reporting these links again. Some studies find no clear mortality link; short and long sleep are also linked with biological-age acceleration. Some authors are company-affiliated, and some papers declare company ties.
562 findings in 429 papers from 2015 to 2026, 103 of them since April 2026
Independent labs found the same change in people. 244 independent labs in 38 countries.
“Performance peaked at 7 h of sleep duration for all three games in the sample as a whole”
86 of its findings point the other way.
- 244 independent labs in 38 countries
- 86 findings against
- Funders: National Institute on Aging and others
- 32 of 547 findings with company ties
- Human trial2
- Humans628
- Model organisms1
- In silico2
What did studies of sleep duration find?
95Studies of sleep duration measured 95 outcomes; the most studied are cognitive function (14 studies), sarcopenia (4) and telomere length (3).
Cognitive function
downin humans7no changein humans3upin humans2mediatesin humans1+1
14 studies
Cognitive function
downin humans7no changein humans3upin humans2mediatesin humans1+1
Sleep duration is linked with better cognitive function in AD with WMH+.
Humansin AD with WMH+n = 735
Sleep duration is linked with lower cognitive function in humans (β -0.05 to -0.03 per SD increase).
Humansn = 27,343
Sleep duration is linked with better cognitive function in humans.
Humans2-weekn = 35
Sleep duration is linked with worse cognitive function in humans (vs. < 9 hours).
Humansvs. < 9 hours14 years
Sleep duration is linked with worse cognitive function in humans.
Humansn = 422,106
Sleep duration is linked with worse cognitive function in humans (compared to those with 6 h sleep) (adjusted β -0.36, 95% CI -0.71 to -0.02).
Humanscompared to those with 6 h sleep≤5 h per day
Sleep duration is linked with cognitive function in humans (association between ADLs and cognitive, depression and dual trajectories) (3.14%, 6.14%, and 2.70% (P < 0.05)).
Humansassociation between ADLs and cognitive, depression and dual trajectories
Sleep duration was not clearly linked with cognitive function in humans (participants using antidepressants without depressive symptoms).
Humansparticipants using antidepressants without depressive symptoms
Sleep duration was not clearly linked with cognitive function in humans (without chronic kidney disease).
Humanswithout chronic kidney diseasen = 3,215
Sleep duration is linked with worse cognitive function in dementia-free participants.
Humansin dementia-free participants
All 14Fewer
Sarcopenia
no changein humans3mediatesin humans1OR 1.081–2.093
4 studies
Sarcopenia
no changein humans3mediatesin humans1OR 1.081–2.093
Sleep duration is linked with sarcopenia in humans (between depression and sarcopenia) (11.8% of total association).
Humansbetween depression and sarcopenian = 4,067
Sleep duration was not clearly linked with sarcopenia in humans (OR 1.081, 95% CI 0.807 to 1.449).
Humans5-yearn = 2,521
Sleep duration was not clearly linked with sarcopenia in humans (adjusted OR 2.093, 95% CI 0.753-5.812, p=0.157).
Humans2-yearfemalesn = 1,353
Sleep duration was not clearly linked with sarcopenia in humans.
Humans
Telomere length
no changein humans2upin humans1
3 studies
Telomere length
no changein humans2upin humans1
Sleep duration is linked with higher telomere length in humans (Mendelian randomization; linear relationship).
HumansMendelian randomization; linear relationshipgenetically predictedleukocyten = 442,664
Sleep duration was not clearly linked with telomere length in humans.
Humans
Sleep duration was not clearly linked with telomere length in humans (adjusted for sociodemographic and health indicators).
Humansadjusted for sociodemographic and health indicatorsn = 2,936
Mortality
no changein humans3
3 studies
Mortality
no changein humans3
Sleep duration was not clearly linked with mortality in humans (Mendelian randomization).
HumansMendelian randomizationn = 451,420
Sleep duration was not clearly linked with mortality in humans among those with existing chronic diseases.
Humansamong those with existing chronic diseases
Sleep duration was not clearly linked with mortality in humans.
Humans< 7 h/night versus 7-8 h/night
Grip strength
downin humans1downin silico1
2 studies
Grip strength
downin humans1downin silico1
Sleep duration is linked with worse grip strength in humans (-0.14 kg per year; 95% CI: -0.26 to -0.03).
Humans≥9 height-year follow-up periodfemalesn = 6,429
Sleep duration impairs grip strength in silico.
In silico
Depressive symptoms
downin humans1no changein humans1
2 studies
Depressive symptoms
downin humans1no changein humans1
Sleep duration is linked with lower depressive symptoms in humans (cross-sectional analysis) (B = -0.548, 95% CI (-0.628, -0.468)).
Humanscross-sectional analysisn = 5,111
Sleep duration was not clearly linked with depressive symptoms in humans (P>0.05).
Humansmales
Lifespan
upin flies1downin Mammalia1
2 studies
Lifespan
upin flies1downin Mammalia1
Sleep duration shortens lifespan in Mammalia.
Review
Sleep duration extends lifespan in flies (short-sleep versus long-sleep Sleep Inbred Panel lines) (∼16% longer life span).
Model organismsshort-sleep versus long-sleep Sleep Inbred Panel lines
Frailty
no changein humans1downin silico1
2 studies
Frailty
no changein humans1downin silico1
Sleep duration was not clearly linked with frailty in humans.
Humansn = 1,643
Sleep duration decreases frailty in silico (β = - 0.36, 95% CI - 0.49 to - 0.22).
In silico
Type 2 diabetes
no changein humans2
2 studies
Type 2 diabetes
no changein humans2
Sleep duration was not clearly linked with type 2 diabetes in humans.
Humansn = 23,023
Sleep duration was not clearly linked with type 2 diabetes in subjects with good sleep quality.
Humansin subjects with good sleep quality
Executive function
downin humans2
2 studies
Executive function
downin humans2
Sleep duration is linked with worse executive function in humans (controlled for age, sex, race/ethnicity, education, and cognitive status) (β=-0.249, 95% CI -0.355 to -0.143).
Humanscontrolled for age, sex, race/ethnicity, education, and cognitive status>8 hours
Sleep duration is linked with worse executive function in humans (p = .015).
Humansfemales
All 95Fewer
What is sleep duration linked with?
268Studies link sleep duration with 268 measures, most often mortality (22 studies), cognitive function (20) and cognitive impairment (13).
Mortality
upin humans17mixedin humans3downin humans2HR 0.78–11.15
22 studies
Mortality
upin humans17mixedin humans3downin humans2HR 0.78–11.15
Sleep duration is associated with mortality in humans (heart disease) (HR 1.51, 95% CI 1.32–1.73).
Humansheart disease≥9 hours versus 7–8 hours15 yearsn = 3,287
Sleep duration is associated with mortality in humans (Advanced (Stage 3–4) cardiovascular-kidney-metabolic syndrome) (HR 1.21, 95% CI 1.00–1.46; P = .05).
HumansAdvanced (Stage 3–4) cardiovascular-kidney-metabolic syndrome>8 hours per night versus 7–8 hoursMedian 7.6 years of follow-upn = 4,266
Sleep duration is associated with mortality in humans (Unfavorable-to-favorable sleep duration versus consistently unfavorable sleep duration) (HR 0.78, 95% CI 0.61–0.99).
HumansUnfavorable-to-favorable sleep duration versus consistently unfavorable sleep durationMedian 9.01 yearsn = 6,374
Sleep duration is linked with a higher risk of mortality in humans (adjusted HR 1.17 (95% CI 1.01-1.35)).
Humans30.8 yearsn = 3,305
Sleep duration is associated with mortality in humans (fully adjusted model) (HR 1.17 (1.01-1.35), P=0.035).
Humansfully adjusted modeln = 435
Sleep duration is associated with mortality in humans.
Humansup to 15 yearsn = 29,997
Sleep duration is linked with a higher risk of mortality in humans (adjusted HR 11.15, 95% CI 6.54–19.01).
Humanshighest Charlson Comorbidity Index category, compared with 7-8 hours sleep and no multimorbidityup to 15 yearsn = 29,997
Sleep duration is associated with mortality in humans (Patients with inflammatory bowel disease) (21% lower risk; HR 0.79, 95% CI 0.66–0.95).
HumansPatients with inflammatory bowel disease7-8 hours per dayMedian 14.6-year follow-upn = 4,262
Sleep duration is associated with mortality in humans (short (<6 hours) and long (>8 hours) sleep compared to normal ([6-8] hours)).
Humansshort (<6 hours) and long (>8 hours) sleep compared to normal ([6-8] hours)
Sleep duration is linked with a higher risk of mortality in humans (long sleep duration (>8 vs 7-8 hours)) (HR 1.27; 95% CI 1.06 to 1.53).
Humanslong sleep duration (>8 vs 7-8 hours)7.36 yearsn = 2,468
All 23Fewer
Cognitive function
downin humans7mixedin humans7upin humans6
20 studies
Cognitive function
downin humans7mixedin humans7upin humans6
Sleep duration is associated with cognitive function in humans (Longer sleep in Alzheimer's disease with WMH+; exploratory finding).
HumansLonger sleep in Alzheimer's disease with WMH+; exploratory finding
Sleep's link to brain damage varies with other vessel injuries
Alzheimer's & dementia : the journal of the Alzheimer's AssociationSleep duration is associated with cognitive function in humans (short (5-6 hours) and long (9-10 hours) sleep duration) (all p < 0.001).
Humansshort (5-6 hours) and long (9-10 hours) sleep durationbrainn = 38,816
Sleep duration is associated with cognitive function in humans.
Humansn = 326
Sleep duration is associated with cognitive function in humans.
Humans
Sleep duration predicts cognitive function in humans.
Humans
Sleep duration is associated with cognitive function in humans.
Humans
Sleep duration is associated with cognitive function in humans (optimal sleep duration 5.8-7 h in CHARLS and 6-6.7 h in SHARE).
Humansoptimal sleep duration 5.8-7 h in CHARLS and 6-6.7 h in SHARE
Sleep duration is associated with cognitive function in humans.
Humans
Sleep duration is associated with cognitive function in humans (overweight and obese (BMI ≥ 25 kg/m2)).
Humansoverweight and obese (BMI ≥ 25 kg/m2)n = 2,243
Sleep duration is associated with cognitive function in humans (cross-sectional analysis) (inflection point at SD = 6 h).
Humanscross-sectional analysis
All 21Fewer
Cognitive impairment
upin humans11downin humans1mixedin humans1OR 1.28–1.96
13 studies
Cognitive impairment
upin humans11downin humans1mixedin humans1OR 1.28–1.96
Sleep duration is linked with a higher risk of cognitive impairment in type 2 diabetic patients aged 60 and above with total daily sleep <6 hours (OR = 1.96, 95% CI: 1.25-3.09).
Humansin type 2 diabetic patients aged 60 and above with total daily sleep <6 hours<6 hoursn = 1,044
Sleep duration is associated with cognitive impairment in humans (Multivariate analysis in community-dwelling older adults).
HumansMultivariate analysis in community-dwelling older adults> 8 hn = 2,830
Sleep duration is linked with a higher risk of cognitive impairment in humans (HR 1.13, 95% CI 1.00-1.28).
Humans7.4 yearsmalesn = 2,670
Sleep duration is linked with a higher risk of cognitive impairment in humans (short sleep duration vs normal sleep duration).
Humansshort sleep duration vs normal sleep duration10-year follow-upn = 4,988
Sleep duration is associated with cognitive impairment in humans.
Humans7–8 hoursn = 186,562
Sleep duration is linked with a higher risk of cognitive impairment in humans (>8 hours/day) (RR = 2.167, 95% CI 1.327∼3.539).
Humans>8 hours/day
Sleep duration is associated with cognitive impairment in humans (unadjusted, compared with 6 h sleep per day) (OR 1.70, 95% CI 1.05-2.74 (insignificant after adjustment)).
Humansunadjusted, compared with 6 h sleep per day≤5 h per day
Sleep duration is linked with a higher risk of cognitive impairment in humans (OR 1.280, 95% CI 1.053-1.557).
Humans
Sleep duration is linked with a higher risk of cognitive impairment in humans (long sleep duration (> 8 h) vs moderate sleep (7-8 h)) (OR 1.41, 95% CI 1.05-1.87).
Humanslong sleep duration (> 8 h) vs moderate sleep (7-8 h)6.9 ± 2.1 yearsn = 623
Sleep duration is linked with a higher risk of cognitive impairment in humans (normal cognition at baseline).
Humansnormal cognition at baseline
All 14Fewer
Frailty
upin humans8downin humans4OR 1.66–1.99
11 studies
Frailty
upin humans8downin humans4OR 1.66–1.99
Sleep duration is linked with a lower risk of frailty in humans.
Humansnormal or long versus short sleep; transition into medium- and high-level increase trajectoriesnormal 6-8 h/day; long >8 h/day
Sleep duration predicts frailty in humans (β = - 0.34, P < 0.001).
Humans
Sleep duration is linked with a higher risk of frailty in humans (compared with normal sleep duration (6-8 h)) (OR = 1.99, 95% CI 1.64-2.41, P < 0.001).
Humanscompared with normal sleep duration (6-8 h)≤ 5 h
Sleep duration is associated with frailty in humans (<5 hours or >8 hours).
Humansn = 2,647
Sleep duration is associated with frailty in humans (r=-0.1741, p=0.0258).
Humansn = 124
Sleep duration is associated with frailty in humans (compared to 7-8 h of sleep) (AOR: 0.68; CI: 0.51-0.91).
Humanscompared to 7-8 h of sleep≥ 9 h
Sleep duration is associated with frailty in humans (compared to optimal-stable group) (OR 1.66, 95% CI 1.13-2.46).
Humanscompared to optimal-stable group
Sleep duration is associated with frailty in humans (< 6 h sleep duration) (16% (95% CI 6%, 28%) higher FI).
Humans< 6 h sleep durationmales
Sleep duration is associated with frailty in humans.
Humans
Sleep duration is linked with a higher risk of frailty in humans (HR 1.13, 95% CI 1.04-1.22).
Humans>8.5 hours
All 12Fewer
Dementia
upin humans7downin humans1+64% riskHR 0.93–2.57
8 studies
Dementia
upin humans7downin humans1+64% riskHR 0.93–2.57
Sleep duration is associated with dementia in humans (HR 0.93; 95% CI 0.86–1.00; p = 0.04).
HumansModels adjusted for sociodemographic and lifestyle behavioral factors; association attenuated in within-pair analyses13.42 yearsn = 13,087
Genetic tendency to nap linked to dementia in Swedish twins
Alzheimer's & dementia : the journal of the Alzheimer's AssociationSleep duration is linked with a higher risk of dementia in humans (cross-sectional) (OR 2.99, 95% CI: 2.47-3.62).
Humanscross-sectional<5 h or >10 hn = 12,187
Sleep duration is linked with a higher risk of dementia in humans (mild cognitive impairment) (HR 2.57, 95% CI 1.62-4.02).
Humansmild cognitive impairment
Sleep duration is linked with a higher risk of dementia in humans (compared to ideal sleep duration (7-8 h)) (+64% risk).
Humanscompared to ideal sleep duration (7-8 h)8 (± 2.9) yearsn = 7,223
Sleep duration is linked with a higher risk of dementia in humans (relative to 7 hours) (adjusted HR 1.46, 95% CI 1.00-2.15).
Humansrelative to 7 hours8.0 yearsn = 13,601
Sleep duration is linked with a higher risk of dementia in humans (vs. 7-8 h) (HR 1.69 (95% CI 1.01-2.83)).
Humansvs. 7-8 hmean follow-up of 3.7 yearsn = 1,982
Sleep duration raises the risk of dementia in humans (compared with 7-8 hours) (short: RR = 1.18, 95% CI = 1.09 to 1.28; long: RR = 1.28, 95% CI = 1.15 to 1.43).
Reviewcompared with 7-8 hours<7 hours or >8 hours
Sleep duration is associated with dementia in older adults with MCI or AD.
Reviewin older adults with MCI or AD
Sarcopenia
upin humans5mixedin humans1downin humans1OR 1.41–2.41
7 studies
Sarcopenia
upin humans5mixedin humans1downin humans1OR 1.41–2.41
Sleep duration is associated with sarcopenia in humans (patients receiving peritoneal dialysis) (U-shaped association; lowest estimated odds at approximately 7.29 h/night).
Humanspatients receiving peritoneal dialysisn = 562
Sleep duration is associated with sarcopenia in humans.
Humans
Sleep duration is linked with a higher risk of sarcopenia in humans (abnormal sleep duration).
Humansabnormal sleep duration
Sleep duration is linked with a higher risk of sarcopenia in humans (long sleep (≥8 h)) (OR 1.41 (95% CI 1.01-2.02), p < 0.05).
Humanslong sleep (≥8 h)
Sleep duration is linked with a higher risk of sarcopenia in humans (OR 2.41, 95% CI 1.13-5.17).
Humans2-yearmalesn = 1,353
Sleep duration is associated with sarcopenia in humans (P < .001).
Humans
Sleep duration raises the risk of sarcopenia in humans (individuals with metabolic syndrome).
Reviewindividuals with metabolic syndrome>9 hours
Telomere length
downin humans3upin humans3mixedin humans1
7 studies
Telomere length
downin humans3upin humans3mixedin humans1
Sleep duration is associated with telomere length in humans (breast cancer survivors).
Humansbreast cancer survivorsexcessivefemalesn = 262
Sleep duration is associated with telomere length in humans (Observational analysis; association shape differed between linear and spline models).
HumansObservational analysis; association shape differed between linear and spline modelsself-reportedleukocyten = 442,664
Sleep duration is associated with telomere length in type 2 diabetes mellitus patients (β=-0.123, 95% CI: -0.229 to -0.017, p=0.022).
Humansin type 2 diabetes mellitus patientsn = 1,027
Sleep duration is associated with telomere length in humans (P = 0.001).
Humansn = 310,091
Sleep duration is associated with telomere length in humans.
Humans
Sleep duration is associated with telomere length in humans (postmenopausal women) (27-base-pair per additional hour (95% CI: 6, 48)).
Humanspostmenopausal womeneach additional daily hour of sleep beyond 5 hoursfemalesn = 3,145
Sleep duration is associated with telomere length in humans (β=0.086, P<0.01).
Humansafter controlling for the effects of gender, age, marital status, income level, residence, smoking, drinking, physical exercise and disease statusleukocyten = 176
Multimorbidity
upin humans4mixedin humans2downin humans1OR 1.63–1.64
7 studies
Multimorbidity
upin humans4mixedin humans2downin humans1OR 1.63–1.64
Sleep duration is associated with multimorbidity in humans (Compared with 6–8 h sleep) (aOR 1.65, 95% CI 1.22–2.25).
HumansCompared with 6–8 h sleep≥9 hn = 2,998
Sleep duration is associated with multimorbidity in humans (Short sleep; fully adjusted model) (OR 1.640, 95% CI 1.505–1.788).
HumansShort sleep; fully adjusted modeln = 18,664
Sleep duration is linked with a higher risk of multimorbidity in humans (Deteriorated sleep duration) (OR = 1.63, 95% CI: 1.09-2.39).
HumansDeteriorated sleep durationn = 1,822
Sleep duration is linked with a lower risk of multimorbidity in humans (hypertension) (aOR 0.768, 95% CI 0.710-0.831).
Humanshypertensionn = 16,953
Sleep duration is associated with multimorbidity in humans (Prolonged sleep in females: HR 1.68, 95% CI 1.17–2.40).
Humansinsufficient and prolonged sleep5 yearsn = 138,126
Sleep duration is associated with multimorbidity in humans.
Humans
Sleep duration is associated with multimorbidity in humans.
Humansn = 19,752
Hypertension
upin humans3mixedin humans2downin humans1OR 0.78–1.33
6 studies
Hypertension
upin humans3mixedin humans2downin humans1OR 0.78–1.33
Sleep duration is associated with hypertension in humans (U.S. adults) (Prevalence 40.1% vs 30.3%; PR 1.32).
HumansU.S. adults≤5 hrs versus 7-9 hrsn = 366,571
Sleep duration is associated with hypertension in humans (older adults in Padang Timur Village).
Humansolder adults in Padang Timur Villagen = 62
Sleep duration is linked with a lower risk of hypertension in humans (OR 0.78, 95% CI 0.64-0.94).
Humans6-7 hn = 5,872
Sleep duration is associated with hypertension in humans (naturally postmenopausal women; insufficient and excessive sleep) (U-shaped association).
Humansnaturally postmenopausal women; insufficient and excessive sleepfemalesn = 3,560
Sleep duration is linked with a higher risk of hypertension in humans (OR 1.27 (95%CI 1.04-1.56)).
Humansadjusted for gender, age, education, economic factors, sitting time, smoking, drinking, obesity<7 h/dn = 4,078
Sleep duration is associated with hypertension in humans (Adjusted for potential confounding variables) (OR 1.33, 95% CI 1.00–1.77).
HumansAdjusted for potential confounding variables≥9 h per 24-h period versus six to eight hoursmalesn = 967
Depressive symptoms
downin humans3upin humans2mixedin humans1
6 studies
Depressive symptoms
downin humans3upin humans2mixedin humans1
Sleep duration is associated with depressive symptoms in humans (Chinese adults; directional lagged association) (β = -0.064, 95% CI: -0.110, -0.018).
HumansChinese adults; directional lagged associationn = 12,747
Sleep duration is associated with depressive symptoms in humans (~ 6.5 h).
Humansn = 10,706
Sleep duration predicts depressive symptoms in humans.
Humans
Sleep duration is associated with depressive symptoms in humans (B = -0.443, P < 0.001).
Humansn = 6,527
Sleep duration is associated with depressive symptoms in humans.
Humans
Sleep duration is associated with depressive symptoms in humans (Interaction with activities of daily living in the regression on depressive symptoms) (8.31–10.19 h sleep duration: range within which the detrimental association of frailty with depressive symptoms was offset).
HumansInteraction with activities of daily living in the regression on depressive symptomsn = 1,429
All 268Fewer
Funding
11 grants since 2018National Heart, Lung, and Blood Institute$1.9MNational Institute on Aging$2.8MJapan Society for the Promotion of Science¥8.8M
National Heart, Lung, and Blood InstituteIcahn School of Medicine at Mount Sinai$191K2022–2027
Japan Society for the Promotion of ScienceNational Center of Neurology and Psychiatry¥4.7M2025–2028
Economic and Social Research CouncilUniversity of Strathclyde2023–2027
Sleep duration Polygenic Risk Score: Association with cognition and brain measures
National Institute on AgingColumbia University Health Sciences$130K2022–2025
National Heart, Lung, and Blood InstituteUniversity of Michigan at Ann Arbor$94.7K2019–2024
Japan Society for the Promotion of ScienceNational Center of Neurology and Psychiatry¥4.2M2022–2025
National Institute on AgingUniversity of Wisconsin-madison$653K2018–2024
National Heart, Lung, and Blood InstituteUniversity of Pittsburgh at Pittsburgh$77.9K2019–2023
Association of habitual sleep duration with plasma metabolomics
National Heart, Lung, and Blood InstituteUniversity of Colorado$125K2019–2022
Gouvernement du Canada | Canadian Institutes of Health ResearchMcGill UniversityCA$5002020
Contains public sector information licensed under the Open Government Licence v3.0.
How this record changed
Summary rewritten as its findings changed.
As it read before
Human observational studies link short or long sleep with mortality and biological-age acceleration; independent labs reproduce links between sleep duration and mortality, cognition and frailty. Some analyses show no clear mortality link. Some papers declare company ties or include company-employed authors.
Summary rewritten as its findings changed.
As it read before
Short and long sleep are linked with higher mortality and biological-age acceleration in human observational studies, with aging measures lowest around seven hours. Independent labs report links with mortality, cognition, and frailty, although some studies find no clear mortality link. Some authors work at companies, and some papers declare company ties.
Summary rewritten as its findings changed.
As it read before
Human observational studies link short or long sleep with mortality, biological-age acceleration and cognitive impairment; independent labs reproduce cognition and frailty associations. Telomere associations differ across studies and models, and 46 findings oppose the predominant direction for their outcome. Some authors work at companies, and seven papers declare company ties.
Summary rewritten as its findings changed.
As it read before
A human study and a review link sleep duration to mortality; another human study associates it with memory in women. The mortality study finds no association with cardiovascular mortality, while the review reports no effect on cancer incidence. Human results comprise three findings from two independent labs, without same-outcome replication.
Summary written from the findings.